Regencell Bioscience (RGC) Cash on Hand per Share

Corporate emblem and logo of Regencell Corp (RGC)

Regencell Bioscience operates a business that is independent of economic cycles, relying instead on regulatory verdicts. The development of its neuro-segment through clinic partnerships is accelerating tests for cognitive treatments, which confirms a shift in the cash position per share. The current 0.03 metric reflects liquidity dynamics. However, the speculative status of the management under Yat-Guy Au is driven by the early stage of product commercialization.

Regencell (RGC) Cash per Share: for the period 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Regencell Corp (RGC)

- market value and analyst target forecast:
- market capitalization details:
- cash position and cash flow details:
Comprehensive company analysis:Regencell RGC
Manufactured product of Regencell

This indicator reflects the net liquidity per common share, allowing for an assessment of the real solvency reserve and the intrinsic value of the business regardless of market manipulations. For Regencell Bioscience (RGC), such a cash cushion is critical for the development of a closed therapeutic circuit for neuropsychiatric drugs, which is clearly evidenced by the trend in cash per share.

Key competitors

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash per Share NBIX|Cash per Share axsome.com (AXSM)|Cash per Share ACAD (acadia-pharm.com)|XENE - Cash per Single Share|vikingtherapeutics.com - Cash per Share|Supernus Pharma (SUPN) - Cash per Single Share|CPRX: Cash per Share|Denali Therapeutics Inc. (DNLI) - Cash per Share|Cash Funds per Share Harmony Pharma|Cash Funds per Share BHVN|Cash per Single Share AMLX (Amylyx Pharmaceuticals, Inc.)|Cash per Single Share Trevi Corp TRVI|Cash Funds per Share praxismedicines.com PRAX|AVXL - Cash per Single Share|CeriBell EEG - Cash per Share|Cash on Hand per Share prothena.com|Alector Therapeutics (ALEC) - Cash Funds per Share|Annexon Biosciences Inc. - Amount of Cash per Share|OMER (Omeros Corp) - Cash per Share|Cash per Share neurogene.com|Cash per Share ACIU|VYGR - Cash on Hand per Share|Cash Funds per Share Neumora Therapeutics Inc NMRA|Cash Funds Calculated per Share Scilex Holding Co. (SCLX)|TVGN - Cash Funds per Share|Cash on Hand per Share alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Cash per Single Share|IKT: Cash Calculated per Single Share|Cash Funds per Share Cassava Sciences, Inc.|ASRT (assertiotx.com) - Cash Calculated per Single Share|Cash Funds per Share Coya (COYA)|VTGN - Cash on Hand per Share|Cash per Share OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Cash on Hand per Share|cervomed.com - Cash per Share|Amount of Cash per Share ATHE (Alterity Therapeutics Limited)|CLNN: Cash per Share|Cash per Single Share PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Cash per Share|Cash on Hand per Share Relmada Therapeutics Inc RLMD|Cash Funds per Share Annovis Bio Corporation (ANVS)|GRCE - Cash on Hand per Share|Cash Funds per Share Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Cash on Hand per Share|NeuroSense Therapeutics, Ltd. - Cash per Share|RVPH: Cash Funds per Share|MTVA: Cash per Share|NRXS - Cash Funds Calculated per Share|HSDT (Helius Medical Technologies Inc.) - Cash per Share|Cash on Hand per Share Passage Bio PASG|Cash Funds per Share Neuphoria (NEUP)|Cash per Share Minerva Neurosciences Corp (NERV)|Cash Funds per Share Athira ATHA|Cash per Share Addex ADXN|Alzamend - Cash per Share|Cash on Hand per Share Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Cash Funds per Share|KTTA: Cash Calculated per Single Share|Cash per Single Share CRGT|Avenue Therapeutics, Inc - Cash Money per Share|Cash Funds per Share Brainstorm Cell (BCLI)|CARA: Cash Money per Share|Chromocell Therapeutics Corp. - Cash per Single Share|Cash Funds Calculated per Share Eliem (ELYM)|ITCI: Cash per Single Share|Amount of Cash per Share LBPH (Longboard)|marinuspharma.com (MRNS) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share